SC / ETH

SC / USDT

VIDT / USDT

ZRO / USDT

LAYER / USDC

LAYER / USDT

ZRO / USDC

LAYER / TRY

CTSI / BTC

ZRO / BTC

AUCTION / USDT

AUCTION / BTC

SNT / USDT

W / BTC

RENDER / EUR

BEAMX / USDT

AUDIO / TRY

BEAMX / TRY

HIVE / FDUSD

FUN / USDT

WOL 3D INDIA LIMITED

VIBHOR STEEL TUBES LTD

MANUGRAPH INDIA LIMITED

SANGINITA CHEMICALS LTD

RAJESH EXPORTS LTD

EURO PANEL PRODUCTS LTD

SML ISUZU LIMITED

SPECIALITY REST LTD

LIKHITHA INFRASTRUC LTD

STEEL EXCHANGE INDIA LTD

KEI INDUSTRIES LTD.

ROCKINGDEALS CIRCU ECO L

NEELAM LINENS & GAR (I) L

P S RAJ STEELS LIMITED

PRAXIS HOME RETAIL LTD

PRAMARA PROMOTIONS LTD

ADROIT INFOTECH LIMITED

KHANDWALA SECURITIES LTD

PREMIUM PLAST LIMITED

SHREE TIRUPATI BALAJEE L

Click here to get full coverage on Indoco Remedies' AnaCipher says USFDA has completed inspection of Hyderabad facility - CNBCTV18

Indoco Remedies' AnaCipher says USFDA has completed inspection of Hyderabad facility  CNBCTV18

Indoco Remedies' AnaCipher says USFDA has completed inspection of Hyderabad facility - CNBCTV18

Click here to get full coverage on Indoco Remedies to Host 10th Annual Analyst Conference - TipRanks

Indoco Remedies to Host 10th Annual Analyst Conference  TipRanks

Indoco Remedies to Host 10th Annual Analyst Conference - TipRanks

Click here to get full coverage on Indoco’s clinical research organisation ‘AnaCipher’ completes USFDA inspection - Indian Pharma Post

Indoco’s clinical research organisation ‘AnaCipher’ completes USFDA inspection  Indian Pharma Post

Indoco’s clinical research organisation ‘AnaCipher’ completes USFDA inspection - Indian Pharma Post

Click here to get full coverage on Indoco Remedies gets warning letter from USFDA for Goa plant - The Economic Times

Indoco Remedies gets warning letter from USFDA for Goa plant  The Economic Times

Indoco Remedies gets warning letter from USFDA for Goa plant - The Economic Times

Click here to get full coverage on Here's why Indoco Remedies shares were under pressure on March 11; details - Business Standard

Here's why Indoco Remedies shares were under pressure on March 11; details  Business Standard

Here's why Indoco Remedies shares were under pressure on March 11; details - Business Standard

Click here to get full coverage on #IndocoRemedies' AnaCipher says #USFDA has completed inspection of #Hyderabad facility - linkedin

#IndocoRemedies' AnaCipher says #USFDA has completed inspection of #Hyderabad facility  linkedin

#IndocoRemedies' AnaCipher says #USFDA has completed inspection of #Hyderabad facility - linkedin

Click here to get full coverage on Indoco Remedies CRO AnaCipher gets one Form 483 from USFDA - Medical Dialogues

Indoco Remedies CRO AnaCipher gets one Form 483 from USFDA  Medical Dialogues

Indoco Remedies CRO AnaCipher gets one Form 483 from USFDA - Medical Dialogues

Click here to get full coverage on Revenues Working Against Indoco Remedies Limited's (NSE:INDOCO) Share Price Following 25% Dive - Simply Wall St

Revenues Working Against Indoco Remedies Limited's (NSE:INDOCO) Share Price Following 25% Dive  Simply Wall St

Revenues Working Against Indoco Remedies Limited's (NSE:INDOCO) Share Price Following 25% Dive - Simply Wall St

Click here to get full coverage on Indoco Remedies shares fall after USFDA warning letter over Goa facility - Moneycontrol

Indoco Remedies shares fall after USFDA warning letter over Goa facility  Moneycontrol

Indoco Remedies shares fall after USFDA warning letter over Goa facility - Moneycontrol

Click here to get full coverage on Indoco Remedies Share Price Hits Over One–Month High After Announcing Partnership With UK Distributor - NDTV Profit

Indoco Remedies Share Price Hits Over One–Month High After Announcing Partnership With UK Distributor  NDTV Profit

Indoco Remedies Share Price Hits Over One–Month High After Announcing Partnership With UK Distributor - NDTV Profit

Click here to get full coverage on Indoco Remedies Cleared of GST Proceedings, No Financial Impact - TipRanks

Indoco Remedies Cleared of GST Proceedings, No Financial Impact  TipRanks

Indoco Remedies Cleared of GST Proceedings, No Financial Impact - TipRanks

Click here to get full coverage on Indoco Remedies slides after Hyderabad facility gets one form 483 from USFDA - Business Standard

Indoco Remedies slides after Hyderabad facility gets one form 483 from USFDA  Business Standard

Indoco Remedies slides after Hyderabad facility gets one form 483 from USFDA - Business Standard

Click here to get full coverage on Indoco Remedies gets USFDA nod to market Lofexidine tablets with 180 days exclusivity - The Economic Times

Indoco Remedies gets USFDA nod to market Lofexidine tablets with 180 days exclusivity  The Economic Times

Indoco Remedies gets USFDA nod to market Lofexidine tablets with 180 days exclusivity - The Economic Times

Click here to get full coverage on Indoco Remedies shares fall over 7% after Goa unit gets USFDA Warning Letter - CNBCTV18

Indoco Remedies shares fall over 7% after Goa unit gets USFDA Warning Letter  CNBCTV18

Indoco Remedies shares fall over 7% after Goa unit gets USFDA Warning Letter - CNBCTV18

Click here to get full coverage on Indoco Remedies Gets US FDA Approval For Opioids drug - NDTV Profit

Indoco Remedies Gets US FDA Approval For Opioids drug  NDTV Profit

Indoco Remedies Gets US FDA Approval For Opioids drug - NDTV Profit

Click here to get full coverage on Private companies who have a significant stake must be disappointed along with institutions after Indoco Remedies Limited's (NSE:INDOCO) market cap dropped by ₹2.5b - Simply Wall St

Private companies who have a significant stake must be disappointed along with institutions after Indoco Remedies Limited's (NSE:INDOCO) market cap dropped by ₹2.5b  Simply Wall St

Private companies who have a significant stake must be disappointed along with institutions after Indoco Remedies Limited's (NSE:INDOCO) market cap dropped by ₹2.5b - Simply Wall St

Click here to get full coverage on Here's why Vinit Bolinjkar is bullish on Indoco Remedies - The Economic Times

Here's why Vinit Bolinjkar is bullish on Indoco Remedies  The Economic Times

Here's why Vinit Bolinjkar is bullish on Indoco Remedies - The Economic Times

Click here to get full coverage on Indoco Remedies' Goa plant classified as OAI by US FDA - Business Standard

Indoco Remedies' Goa plant classified as OAI by US FDA  Business Standard

Indoco Remedies' Goa plant classified as OAI by US FDA - Business Standard

Click here to get full coverage on Indoco Remedies partners with Clarity Pharma to launch 20 products in UK market - CNBCTV18

Indoco Remedies partners with Clarity Pharma to launch 20 products in UK market  CNBCTV18

Indoco Remedies partners with Clarity Pharma to launch 20 products in UK market - CNBCTV18

Click here to get full coverage on Indoco Remedies drops 4% on weak Q3 performance; revenue falls 11% YoY - Business Standard

Indoco Remedies drops 4% on weak Q3 performance; revenue falls 11% YoY  Business Standard

Indoco Remedies drops 4% on weak Q3 performance; revenue falls 11% YoY - Business Standard

Click here to get full coverage on Indoco Remedies' (NSE:INDOCO three-year decrease in earnings delivers investors with a 27% loss - Simply Wall St

Indoco Remedies' (NSE:INDOCO three-year decrease in earnings delivers investors with a 27% loss  Simply Wall St

Indoco Remedies' (NSE:INDOCO three-year decrease in earnings delivers investors with a 27% loss - Simply Wall St

Click here to get full coverage on ₹294: That's What Analysts Think Indoco Remedies Limited (NSE:INDOCO) Is Worth After Its Latest Results - Simply Wall St

₹294: That's What Analysts Think Indoco Remedies Limited (NSE:INDOCO) Is Worth After Its Latest Results  Simply Wall St

₹294: That's What Analysts Think Indoco Remedies Limited (NSE:INDOCO) Is Worth After Its Latest Results - Simply Wall St

Click here to get full coverage on Indoco Remedies Share Price Plummets As Goa Facility Receives USFDA Warning - NDTV Profit

Indoco Remedies Share Price Plummets As Goa Facility Receives USFDA Warning  NDTV Profit

Indoco Remedies Share Price Plummets As Goa Facility Receives USFDA Warning - NDTV Profit

Click here to get full coverage on Indoco Remedies stock soars over 5% on USFDA approval for opioids drug - Business Standard

Indoco Remedies stock soars over 5% on USFDA approval for opioids drug  Business Standard

Indoco Remedies stock soars over 5% on USFDA approval for opioids drug - Business Standard

Click here to get full coverage on Indoco Remedies gets USFDA nod to market generic diabetes drug - The Economic Times

Indoco Remedies gets USFDA nod to market generic diabetes drug  The Economic Times

Indoco Remedies gets USFDA nod to market generic diabetes drug - The Economic Times

Click here to get full coverage on Indoco Remedies zooms 5% after USFDA approval for anti-smoking drug - Business Standard

Indoco Remedies zooms 5% after USFDA approval for anti-smoking drug  Business Standard

Indoco Remedies zooms 5% after USFDA approval for anti-smoking drug - Business Standard

Click here to get full coverage on Indoco Remedies receives USFDA approval for Lofexidine Tablets 0.18 mg - Business Standard

Indoco Remedies receives USFDA approval for Lofexidine Tablets 0.18 mg  Business Standard

Indoco Remedies receives USFDA approval for Lofexidine Tablets 0.18 mg - Business Standard

Click here to get full coverage on Indoco Remedies gets USFDA nod for Cetirizine tablets, shares surge 3% - CNBCTV18

Indoco Remedies gets USFDA nod for Cetirizine tablets, shares surge 3%  CNBCTV18

Indoco Remedies gets USFDA nod for Cetirizine tablets, shares surge 3% - CNBCTV18

Click here to get full coverage on Indoco Remedies Q3 Results: Company Slips Into Loss, Revenue Declines 10.6% - NDTV Profit

Indoco Remedies Q3 Results: Company Slips Into Loss, Revenue Declines 10.6%  NDTV Profit

Indoco Remedies Q3 Results: Company Slips Into Loss, Revenue Declines 10.6% - NDTV Profit

Click here to get full coverage on Indoco Remedies plunges 8% after warning letter from USFDA for Goa unit - Business Standard

Indoco Remedies plunges 8% after warning letter from USFDA for Goa unit  Business Standard

Indoco Remedies plunges 8% after warning letter from USFDA for Goa unit - Business Standard

Click here to get full coverage on Hold Indoco Remedies; target of Rs 325: Prabhudas Lilladher - Moneycontrol

Hold Indoco Remedies; target of Rs 325: Prabhudas Lilladher  Moneycontrol

Hold Indoco Remedies; target of Rs 325: Prabhudas Lilladher - Moneycontrol

Click here to get full coverage on Indoco Remedies’ Goa facilities receive 'Official Action Indicated' status from USFDA following inspection - CNBCTV18

Indoco Remedies’ Goa facilities receive 'Official Action Indicated' status from USFDA following inspection  CNBCTV18

Indoco Remedies’ Goa facilities receive 'Official Action Indicated' status from USFDA following inspection - CNBCTV18

Click here to get full coverage on Indoco Remedies Q3 Results Review — Regulated Market Performance Remains Subdued; Systematix Retains Hold - NDTV Profit

Indoco Remedies Q3 Results Review — Regulated Market Performance Remains Subdued; Systematix Retains Hold  NDTV Profit

Indoco Remedies Q3 Results Review — Regulated Market Performance Remains Subdued; Systematix Retains Hold - NDTV Profit

Click here to get full coverage on Stock Radar: Indoco Remedies breaks out from inverse head & shoulder pattern; time to buy? - The Economic Times

Stock Radar: Indoco Remedies breaks out from inverse head & shoulder pattern; time to buy?  The Economic Times

Stock Radar: Indoco Remedies breaks out from inverse head & shoulder pattern; time to buy? - The Economic Times

Click here to get full coverage on Indoco Remedies shares rise over 3% on USFDA nod for allergy drug - Business Standard

Indoco Remedies shares rise over 3% on USFDA nod for allergy drug  Business Standard

Indoco Remedies shares rise over 3% on USFDA nod for allergy drug - Business Standard

Click here to get full coverage on Indoco Remedies gets 7 USFDA observations for Goa facilities - Medical Dialogues

Indoco Remedies gets 7 USFDA observations for Goa facilities  Medical Dialogues

Indoco Remedies gets 7 USFDA observations for Goa facilities - Medical Dialogues

Click here to get full coverage on Stock Radar | Trendline breakout from declining channel makes Indoco Remedies an attractive buy: Shitij Gandhi - The Economic Times

Stock Radar | Trendline breakout from declining channel makes Indoco Remedies an attractive buy: Shitij Gandhi  The Economic Times

Stock Radar | Trendline breakout from declining channel makes Indoco Remedies an attractive buy: Shitij Gandhi - The Economic Times

Click here to get full coverage on Indoco Remedies Q2 Results: Loss at ₹9.57Cr, Revenue Decreased by 10.19% YoY - Mint

Indoco Remedies Q2 Results: Loss at ₹9.57Cr, Revenue Decreased by 10.19% YoY  Mint

Indoco Remedies Q2 Results: Loss at ₹9.57Cr, Revenue Decreased by 10.19% YoY - Mint

Click here to get full coverage on Indoco Remedies receives USFDA approval for Cetirizine Hydrochloride Tablets - Business Standard

Indoco Remedies receives USFDA approval for Cetirizine Hydrochloride Tablets  Business Standard

Indoco Remedies receives USFDA approval for Cetirizine Hydrochloride Tablets - Business Standard

Click here to get full coverage on Indoco Remedies update on USFDA inspection of its facilities in Goa - Business Standard

Indoco Remedies update on USFDA inspection of its facilities in Goa  Business Standard

Indoco Remedies update on USFDA inspection of its facilities in Goa - Business Standard

Click here to get full coverage on Indoco Remedies Faces Significant Market Challenges Amidst Declining Stock Performance - MarketsMojo

Indoco Remedies Faces Significant Market Challenges Amidst Declining Stock Performance  MarketsMojo

Indoco Remedies Faces Significant Market Challenges Amidst Declining Stock Performance - MarketsMojo

Click here to get full coverage on Indoco Remedies gets USFDA nod for smoking cessation drug; stock rises - BusinessLine

Indoco Remedies gets USFDA nod for smoking cessation drug; stock rises  BusinessLine

Indoco Remedies gets USFDA nod for smoking cessation drug; stock rises - BusinessLine

Click here to get full coverage on Stocks to Watch Today: IndusInd Bank, Hitachi Energy, NTPC, Syngene, MSTC, HEG, Anupam Rasayan, Nectar... - Moneycontrol

Stocks to Watch Today: IndusInd Bank, Hitachi Energy, NTPC, Syngene, MSTC, HEG, Anupam Rasayan, Nectar...  Moneycontrol

Stocks to Watch Today: IndusInd Bank, Hitachi Energy, NTPC, Syngene, MSTC, HEG, Anupam Rasayan, Nectar... - Moneycontrol

Click here to get full coverage on INDOCO REMEDIES GOA STERILE PLANTS RECEIVED WARNING LETTER - ICICI Direct

INDOCO REMEDIES GOA STERILE PLANTS RECEIVED WARNING LETTER  ICICI Direct

INDOCO REMEDIES GOA STERILE PLANTS RECEIVED WARNING LETTER - ICICI Direct

Click here to get full coverage on Vaibhav Sinha joins Indoco Remedies - Medical Dialogues

Vaibhav Sinha joins Indoco Remedies  Medical Dialogues

Vaibhav Sinha joins Indoco Remedies - Medical Dialogues

Click here to get full coverage on Indoco Remedies enters into distribution partnership with Clarity Pharma - Medical Dialogues

Indoco Remedies enters into distribution partnership with Clarity Pharma  Medical Dialogues

Indoco Remedies enters into distribution partnership with Clarity Pharma - Medical Dialogues

Click here to get full coverage on Indoco Remedies receives warning letter from USFDA for Goa facility - Medical Dialogues

Indoco Remedies receives warning letter from USFDA for Goa facility  Medical Dialogues

Indoco Remedies receives warning letter from USFDA for Goa facility - Medical Dialogues

Click here to get full coverage on Indoco Remedies Consolidated December 2024 Net Sales at Rs 410.55 crore, down 10.64% Y-o-Y - Moneycontrol

Indoco Remedies Consolidated December 2024 Net Sales at Rs 410.55 crore, down 10.64% Y-o-Y  Moneycontrol

Indoco Remedies Consolidated December 2024 Net Sales at Rs 410.55 crore, down 10.64% Y-o-Y - Moneycontrol

Click here to get full coverage on Indoco Remedies Standalone December 2024 Net Sales at Rs 372.98 crore, down 16.94% Y-o-Y - Moneycontrol

Indoco Remedies Standalone December 2024 Net Sales at Rs 372.98 crore, down 16.94% Y-o-Y  Moneycontrol

Indoco Remedies Standalone December 2024 Net Sales at Rs 372.98 crore, down 16.94% Y-o-Y - Moneycontrol

Click here to get full coverage on Small Cap Stock Has Slumped 14% This Year, But Brokerage Sees 98% Upside Ahead - Benzinga India

Small Cap Stock Has Slumped 14% This Year, But Brokerage Sees 98% Upside Ahead  Benzinga India

Small Cap Stock Has Slumped 14% This Year, But Brokerage Sees 98% Upside Ahead - Benzinga India

Click here to get full coverage on Indoco Remedies drops as Goa unit gets OAI status from USFDA - Business Standard

Indoco Remedies drops as Goa unit gets OAI status from USFDA  Business Standard

Indoco Remedies drops as Goa unit gets OAI status from USFDA - Business Standard

Click here to get full coverage on Indoco Remedies receives OAI status from USFDA for Goa plant 2 & 3 - Indian Pharma Post

Indoco Remedies receives OAI status from USFDA for Goa plant 2 & 3  Indian Pharma Post

Indoco Remedies receives OAI status from USFDA for Goa plant 2 & 3 - Indian Pharma Post

Click here to get full coverage on Indoco Remedies receives U.S. FDA approval for generic Cetirizine tablets - Express Pharma

Indoco Remedies receives U.S. FDA approval for generic Cetirizine tablets  Express Pharma

Indoco Remedies receives U.S. FDA approval for generic Cetirizine tablets - Express Pharma

Click here to get full coverage on Indoco Remedies receives USFDA approval for allergy drug Cetirizine Hydrochloride - Medical Dialogues

Indoco Remedies receives USFDA approval for allergy drug Cetirizine Hydrochloride  Medical Dialogues

Indoco Remedies Limited (INDOCO)

Price Chart

Key Statistics

Technicals

About INDOCO

Latest News

Indoco Remedies' AnaCipher says USFDA has completed inspection of Hyderabad facility - CNBCTV18

Indoco Remedies to Host 10th Annual Analyst Conference - TipRanks

Indoco’s clinical research organisation ‘AnaCipher’ completes USFDA inspection - Indian Pharma Post

Advanced Charts

Top Gainers

Top Losers